{"gene":"DAP3","run_date":"2026-06-09T22:57:19","timeline":{"discoveries":[{"year":1995,"finding":"DAP3 was identified as a positive mediator of interferon-gamma-induced cell death in HeLa cells. Antisense RNA-mediated inactivation of DAP3 protected cells from IFN-γ-induced cell death, and ectopic overexpression was incompatible with cell growth. The protein carries a potential P-loop (nucleotide-binding) motif.","method":"Antisense cDNA library functional selection screen; antisense RNA knockdown; ectopic overexpression with colony-formation assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — functional genetic selection, antisense knockdown, and overexpression phenotype; foundational paper replicated by subsequent studies","pmids":["7499268"],"is_preprint":false},{"year":1999,"finding":"Structure-function analysis showed that the intact full-length DAP3 protein is required for apoptosis induction when overexpressed, while the N-terminal 230 amino acids act in a dominant-negative fashion. Both activities depend on the integrity of the nucleotide-binding (P-loop) motif. Antisense DAP3 and the dominant-negative form protected cells from Fas- and TNF-α-induced apoptosis, placing DAP3 downstream of the receptor signaling complex; its death-promoting effect is caspase-dependent. A C. elegans ortholog induced cell death in mammalian cells upon overexpression.","method":"Antisense RNA knockdown; truncation/dominant-negative mutant overexpression; P-loop mutagenesis; caspase inhibitor epistasis; cross-species functional complementation","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (mutagenesis, dominant-negative, epistasis), replicated across stimuli and species","pmids":["9889192"],"is_preprint":false},{"year":2000,"finding":"DAP3 interacts with the glucocorticoid receptor (GR) ligand-binding domain in a ligand-dependent manner, identified by yeast two-hybrid and confirmed in vitro. The main interaction domain maps to the N-terminal region of DAP3. Co-transfection showed DAP3 stimulates ligand-induced GR transcriptional activation and increases steroid sensitivity. DAP3 also formed complexes with other nuclear receptors, bHLH/PAS proteins, and Hsp90.","method":"Yeast two-hybrid; in vitro binding assay; co-transfection transcriptional reporter assay; co-immunoprecipitation","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid plus in vitro interaction plus functional co-transfection assay, single lab","pmids":["10903152"],"is_preprint":false},{"year":2001,"finding":"A conserved N-terminal sequence targets DAP3 to mitochondria. GFP fusion with the N-terminal region of human DAP3 localized exclusively to mitochondria in transfected human fibroblasts, confirmed by confocal microscopy. The mitochondrial targeting sequence is conserved in mouse, Drosophila, and C. elegans orthologs.","method":"N-terminal DAP3–EGFP fusion protein; confocal fluorescence microscopy in transfected human fibroblasts; in silico targeting prediction (MITOPROT, TargetP) with experimental validation","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct live-cell fluorescence localization with functional GFP fusion, single lab","pmids":["11162496"],"is_preprint":false},{"year":2002,"finding":"Co-expression of DAP3 and GR results in increased cellular GR protein levels and partial translocation of DAP3 to the nucleus. The full-length DAP3 (not just the N-terminal domain) is required to efficiently increase GR levels and enhance GR transcriptional activity, indicating interplay between N- and C-termini for DAP3 cellular function.","method":"Co-transfection; western blot; subcellular fractionation/immunofluorescence for DAP3 localization; transcriptional reporter assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 / Moderate — functional co-expression data with domain dissection, single lab, two orthogonal readouts","pmids":["12099703"],"is_preprint":false},{"year":2002,"finding":"DAP3 remains intra-mitochondrial during TRAIL-induced apoptosis and does not interact with FADD when subcellular compartments are intact. Interaction between DAP3 and FADD was only detectable in whole-cell lysate co-immunoprecipitation (i.e., an in vitro artifact after compartment disruption). TRAIL-induced, DR4-mediated apoptosis in Jurkat cells was found to be independent of DAP3.","method":"Cell fractionation; immunoprecipitation with intact vs. disrupted compartments; TRAIL-induced apoptosis in Jurkat cells with DAP3 analysis","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rigorous fractionation controls demonstrating compartment artifact, negative result well-supported; single lab","pmids":["12359235"],"is_preprint":false},{"year":2004,"finding":"DAP3 is critical for anoikis induction. DAP3 knockdown (antisense oligonucleotides) inhibited anoikis, while overexpression augmented caspase activation upon cell detachment. Upon detachment, DAP3 associates with FADD and caspase-8 is activated. DAP3 is phosphorylated by Akt (PKB), and active Akt suppresses DAP3-induced apoptosis; mutation of the Akt phosphorylation consensus site in DAP3 renders it resistant to Akt suppression. Integrin ligation activates Akt, which phosphorylates DAP3 and suppresses anoikis.","method":"Antisense oligonucleotide knockdown; overexpression; co-immunoprecipitation (DAP3-FADD); caspase activation assay; Akt phosphorylation site mutagenesis; integrin ligation experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods including mutagenesis of phosphorylation site, Co-IP, functional rescue, and kinase assay in a single focused study","pmids":["15302871"],"is_preprint":false},{"year":2006,"finding":"DAP3 is essential for embryonic viability in mice; dap3-/- embryos die at ~E9.5 with arrested development, shrunken mitochondria with swollen cristae (by TEM), and reduced cytochrome c oxidase-I (mitochondrial genome-encoded), consistent with a role in mitochondrial protein synthesis. siRNA knockdown reduced oxygen consumption in cultured cells. Cultured dap3-/- embryonic cells showed impaired apoptosis in response to extrinsic stimuli (TNFα, TRAIL, anti-Fas) but not intrinsic (mitochondrial) pathway stimuli.","method":"Knockout mouse generation; transmission electron microscopy; western blot for mtDNA-encoded protein (COX-I); siRNA knockdown + oxygen consumption measurement; cultured embryonic cell apoptosis assays with death receptor stimuli","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo KO phenotype combined with multiple orthogonal functional assays (TEM, respiration, apoptosis pathway specificity)","pmids":["17135360"],"is_preprint":false},{"year":2008,"finding":"DAP3 (mitochondrial ribosomal small subunit protein MRPS29) is phosphorylated in situ at Ser215 or Thr216, Ser220, Ser251 or Ser252, and Ser280, mapped by tandem mass spectrometry. Protein kinase A and Protein kinase Cδ can phosphorylate recombinant DAP3 at these same residues in vitro. Phosphorylation sites cluster around the conserved GTP-binding motifs. Site-directed mutagenesis of selected phosphorylation sites affected cell proliferation and PARP cleavage (caspase activation).","method":"Tandem mass spectrometry of immunopurified mitochondrial ribosomal DAP3; in vitro kinase assay with PKA and PKCδ; site-directed mutagenesis; PARP cleavage assay","journal":"Protein science","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mass spectrometry phosphosite mapping + in vitro kinase validation + mutagenesis with functional readout, single lab","pmids":["18227431"],"is_preprint":false},{"year":2008,"finding":"hNOA1 (human homolog of AtNOA1, a large mitochondrial GTPase) physically interacts with DAP3 in mitochondria, identified by immunoprecipitation-mass spectrometry from enriched mitochondrial fractions. hNOA1 is peripherally associated with the inner mitochondrial membrane facing the matrix. Knockdown of hNOA1 renders cells more resistant to apoptotic stimuli (IFN-γ, staurosporine), consistent with a functional link through its DAP3 interaction.","method":"Immunoprecipitation-mass spectrometry from mitochondrial fractions; immunofluorescence; immunoelectron microscopy; mitochondrial subfractionation; siRNA knockdown + apoptosis assay","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — IP-MS interaction from native mitochondrial fractions plus functional knockdown phenotype, single lab","pmids":["19103604"],"is_preprint":false},{"year":2009,"finding":"IPS-1 (interferon-beta promoter stimulator 1, also known as MAVS) binds DAP3 and is required for DAP3-mediated anoikis. Cell detachment induces IPS-1 expression, recruitment of caspase-8 to IPS-1, and caspase-8 activation. IPS-1 knockout mouse embryonic fibroblasts are resistant to anoikis. Knockdown of IPS-1 inhibits DAP3-mediated anoikis, placing IPS-1 downstream of or in concert with DAP3 in this pathway.","method":"Co-immunoprecipitation (IPS-1/DAP3 interaction); IPS-1 KO MEFs; siRNA knockdown of IPS-1; overexpression of IPS-1; caspase-3/-8/-9 activation assays; anoikis assay","journal":"Cell death and differentiation","confidence":"High","confidence_rationale":"Tier 2 / Strong — Co-IP, genetic KO, siRNA knockdown, and overexpression with multiple caspase readouts in multiple orthogonal approaches","pmids":["19644511"],"is_preprint":false},{"year":2010,"finding":"Yeast two-hybrid screening identified DELE (death ligand signal enhancer) as a novel DAP3-binding protein. DELE interaction with DAP3 was confirmed in mammalian cells by co-immunoprecipitation. Stable DELE expression sensitized cells to TNF-α- and TRAIL-induced apoptosis; DELE knockdown rescued HeLa cells from apoptosis and significantly inhibited activation of caspase-3, -8, and -9 induced by TNF-α, anti-Fas, or TRAIL.","method":"Yeast two-hybrid screening; co-immunoprecipitation in mammalian cells; stable overexpression; siRNA knockdown; caspase activation assays","journal":"Apoptosis","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — yeast two-hybrid confirmed by Co-IP with gain- and loss-of-function phenotyping, single lab","pmids":["20563667"],"is_preprint":false},{"year":2020,"finding":"DAP3 functions as a potent repressor of A-to-I RNA editing in cancer by directly interacting with the deaminase domain of ADAR2, disrupting ADAR2's association with its target transcripts. This suppression of editing leads to accumulation of unedited, more tumorigenic forms of target transcripts (e.g., PDZD7 without stop-codon recoding).","method":"Co-immunoprecipitation (DAP3-ADAR2 interaction); domain-mapping pulldown; RNA immunoprecipitation; editome sequencing; functional assays of PDZD7 recoding","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus RNA-IP plus functional RNA editing assays, single lab, multiple methods","pmids":["32596459"],"is_preprint":false},{"year":2022,"finding":"DAP3 functions as a splicing regulatory RNA-binding protein in cancer. It coordinates splicing regulatory networks by mediating formation of ribonucleoprotein complexes to induce substrate-specific splicing changes, and also modulates splicing of splicing factors themselves, causing indirect widespread alternative splicing effects. Non-productive splicing of WSB1 was demonstrated as a causal DAP3-modulated mis-splicing event in tumorigenesis.","method":"RNA-seq splicing analysis; RNA immunoprecipitation; ribonucleoprotein complex co-immunoprecipitation; TCGA pan-cancer splicing analysis; functional WSB1 splicing validation","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-IP, RNP complex Co-IP, and functional validation of specific splicing target, single lab with pan-cancer computational validation","pmids":["35379802"],"is_preprint":false},{"year":2024,"finding":"DAP3 promotes mitochondrial complex I activity in HCC cells by regulating translation and expression of the mitochondrial genome-encoded MT-ND5. AKT-mediated phosphorylation of DAP3 at Ser185 is the key event mediating its mitochondrial localization and function in HCC cells.","method":"siRNA knockdown; overexpression; mitochondrial complex I activity assay; western blot for MT-ND5; Ser185 phosphorylation site mutagenesis; subcellular fractionation; in vitro and in vivo tumor models","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional mutagenesis of phosphorylation site plus complex I activity assay plus localization, single lab, multiple methods","pmids":["39080251"],"is_preprint":false},{"year":2024,"finding":"Bi-allelic loss-of-function variants in DAP3 reduce MRPS29 (DAP3) protein levels, causing decreased assembly of the mitoribosomal small subunit and combined deficiency of oxidative phosphorylation complexes I and IV. Lentiviral rescue with wild-type DAP3 cDNA partially restored MRPS7, MRPS9, and complex I/IV subunit levels. In vitro assays showed DAP3 disease variants reduce GTPase activity, thermal stability, and both intrinsic and extrinsic apoptotic sensitivity. Protein modeling suggested variants impact ADP binding.","method":"Proteomic profiling of patient fibroblasts; respiratory chain activity measurement; lentiviral cDNA rescue; in vitro GTPase activity assay; thermal stability assay; apoptosis sensitivity assays; protein structural modeling","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multiple orthogonal methods (proteomics, enzymatic assay, genetic rescue, functional apoptosis assays) in a rigorous human genetics study","pmids":["39701103"],"is_preprint":false},{"year":2024,"finding":"DAP3 preserves m6A RNA methylation levels through two mechanisms: (1) it directly binds to m6A target regions on RNA, facilitating METTL3 binding to these sites; and (2) it promotes MAT2A last-intron splicing, increasing MAT2A protein, cellular SAM (methyl donor), and m6A levels. DAP3 silencing impairs tumorigenesis, which can be rescued by MAT2A overexpression.","method":"m6A sequencing; RNA immunoprecipitation; METTL3 ChIP/RIP; MAT2A splicing assay; SAM quantification; MAT2A overexpression rescue; tumor growth assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — RNA-IP plus m6A sequencing plus functional rescue, single lab, two orthogonal mechanistic pathways described","pmids":["39316047"],"is_preprint":false},{"year":2023,"finding":"DAP3 knockdown attenuated radiation-induced G2/M cell cycle arrest in human lung adenocarcinoma cells and decreased expression of phosphorylated cdc2 (Tyr15) and phosphorylated CHK1 (Ser296). A CHK1 inhibitor phenocopied DAP3 loss in abrogating G2 arrest, placing DAP3 upstream of CHK1-mediated G2/M checkpoint regulation in the radiation response.","method":"siRNA knockdown of DAP3; flow cytometry cell cycle analysis after irradiation; western blot for phospho-cdc2, phospho-CHK1; CHK1 inhibitor epistasis; radiosensitivity assay","journal":"Journal of radiation research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — siRNA knockdown with pharmacological epistasis (CHK1 inhibitor), two orthogonal readouts, single lab","pmids":["37023702"],"is_preprint":false}],"current_model":"DAP3 (MRPS29) is a GTP-binding protein of the mitoribosomal small subunit that is targeted to the mitochondrial matrix via a conserved N-terminal sequence, where it is required for mitoribosomal small subunit assembly and mitochondrial translation (especially of MT-ND5), supporting oxidative phosphorylation; it is regulated by phosphorylation at multiple sites (by PKA, PKCδ, and AKT at Ser185), with AKT-mediated phosphorylation also controlling its mitochondrial localization and apoptotic function; outside the mitoribosome, DAP3 acts as a positive mediator of extrinsic (Fas, TNF-α, TRAIL) apoptosis signaling downstream of death receptors in a caspase-dependent manner, interacting with partners including FADD (via IPS-1/MAVS scaffold), DELE1, and the glucocorticoid receptor; additionally, DAP3 functions in the nucleus/cytoplasm as an RNA-binding protein that suppresses A-to-I RNA editing by disrupting ADAR2–substrate interactions, regulates alternative splicing by forming ribonucleoprotein complexes and modulating splicing factor expression, and maintains m6A RNA methylation by facilitating METTL3 binding and promoting MAT2A splicing."},"narrative":{"mechanistic_narrative":"DAP3 (MRPS29) is a GTP-binding protein of the mitoribosomal small subunit that supports mitochondrial translation and a death-promoting signaling protein that mediates extrinsic apoptosis [PMID:7499268, PMID:17135360]. A conserved N-terminal sequence targets DAP3 to mitochondria, where it is required for synthesis of mitochondrial genome-encoded proteins and oxidative phosphorylation: dap3-null mouse embryos die at ~E9.5 with abnormal mitochondria and reduced COX-I, and DAP3 promotes complex I activity by controlling translation of MT-ND5 [PMID:11162496, PMID:17135360, PMID:39080251]. Bi-allelic loss-of-function variants reduce DAP3 protein, impair small-subunit assembly, and cause combined OXPHOS complex I/IV deficiency, establishing DAP3 as a Mendelian mitochondrial disease gene [PMID:39701103]. The death-promoting activity of DAP3 acts downstream of death receptors (Fas, TNF-α) and during anoikis in a caspase-dependent manner, requiring an intact P-loop and full-length protein, and depends on partners including FADD, caspase-8, and the IPS-1/MAVS scaffold [PMID:9889192, PMID:15302871, PMID:19644511]. DAP3 function is gated by phosphorylation: PKA and PKCδ phosphorylate residues clustered around its GTP-binding motifs, and AKT phosphorylation at Ser185 controls both its mitochondrial localization and its suppression of apoptosis [PMID:18227431, PMID:15302871, PMID:39080251]. Independently, DAP3 acts as an RNA-binding regulator in cancer, repressing A-to-I editing by disrupting ADAR2–substrate contacts, reshaping alternative splicing through ribonucleoprotein complexes, and sustaining m6A methylation by facilitating METTL3 binding and MAT2A splicing [PMID:32596459, PMID:35379802, PMID:39316047].","teleology":[{"year":1995,"claim":"Established DAP3 as a required positive mediator of cytokine-induced cell death, defining its founding pro-apoptotic identity and flagging a nucleotide-binding motif as functionally central.","evidence":"Antisense functional selection screen and overexpression in HeLa cells","pmids":["7499268"],"confidence":"High","gaps":["Molecular mechanism of death promotion unresolved","P-loop function not yet tested by mutagenesis"]},{"year":1999,"claim":"Localized DAP3 action downstream of death receptors and showed its death activity is P-loop- and caspase-dependent, mapping where in the apoptotic cascade it operates.","evidence":"Dominant-negative/truncation and P-loop mutagenesis, caspase inhibitor epistasis, cross-species complementation","pmids":["9889192"],"confidence":"High","gaps":["Direct binding partners in the receptor complex not identified","Biochemical role of nucleotide binding unknown"]},{"year":2000,"claim":"Identified DAP3 as a ligand-dependent glucocorticoid receptor coactivator, suggesting a nuclear-receptor regulatory role distinct from apoptosis.","evidence":"Yeast two-hybrid, in vitro binding, co-transfection reporter and Co-IP","pmids":["10903152"],"confidence":"Medium","gaps":["Single lab; physiological relevance unconfirmed","Reconciliation with mitochondrial localization not addressed"]},{"year":2001,"claim":"Demonstrated a conserved N-terminal mitochondrial targeting sequence, placing DAP3 in mitochondria and reframing its biology around organellar function.","evidence":"N-terminal DAP3-EGFP fusion and confocal microscopy in human fibroblasts","pmids":["11162496"],"confidence":"Medium","gaps":["Submitochondrial location not defined","Function within mitochondria not yet shown"]},{"year":2002,"claim":"Clarified that the DAP3-FADD interaction reported in lysates is a compartment-disruption artifact and that TRAIL/DR4 apoptosis can proceed independently of DAP3, tempering the death-receptor model.","evidence":"Intact vs. disrupted compartment Co-IP and TRAIL apoptosis assays in Jurkat cells","pmids":["12359235"],"confidence":"Medium","gaps":["Context-dependence of DAP3-FADD interaction unresolved","Single cell type tested"]},{"year":2004,"claim":"Connected DAP3 to anoikis and identified AKT phosphorylation as a switch suppressing its death function, linking integrin/survival signaling to DAP3 regulation.","evidence":"Antisense knockdown, overexpression, DAP3-FADD Co-IP, AKT site mutagenesis and integrin ligation","pmids":["15302871"],"confidence":"High","gaps":["Exact AKT site not yet mapped","How phosphorylation alters DAP3 activity mechanistically unknown"]},{"year":2006,"claim":"Proved DAP3 is essential for embryonic viability and mitochondrial protein synthesis/respiration, and that its requirement is specific to extrinsic apoptosis, unifying its mitochondrial and death roles in vivo.","evidence":"dap3 knockout mice, TEM, COX-I western, siRNA respiration assay, pathway-specific apoptosis assays","pmids":["17135360"],"confidence":"High","gaps":["Specific mitoribosomal substrates not defined","Molecular link between translation defect and apoptosis sensitivity unclear"]},{"year":2008,"claim":"Mapped DAP3 phosphosites clustering around its GTP-binding motifs and identified PKA/PKCδ as kinases, showing phosphorylation tunes proliferation and caspase activation.","evidence":"Tandem MS phosphosite mapping, in vitro kinase assays, mutagenesis with PARP cleavage readout","pmids":["18227431"],"confidence":"High","gaps":["In vivo stoichiometry and regulation of each site unknown","Functional consequence per site not fully dissected"]},{"year":2008,"claim":"Identified hNOA1 as a matrix-facing mitochondrial GTPase partner of DAP3 with a corresponding apoptosis phenotype, expanding the mitochondrial interactome.","evidence":"IP-MS from mitochondrial fractions, immuno-EM, subfractionation, siRNA apoptosis assay","pmids":["19103604"],"confidence":"Medium","gaps":["Functional consequence of the interaction for translation not shown","Single lab"]},{"year":2009,"claim":"Placed IPS-1/MAVS as a required partner in DAP3-mediated anoikis, providing a scaffold for caspase-8 recruitment during detachment.","evidence":"Co-IP, IPS-1 KO MEFs, siRNA/overexpression, caspase-3/8/9 assays, anoikis assay","pmids":["19644511"],"confidence":"High","gaps":["Direct vs. indirect DAP3-IPS-1 binding not resolved","How mitochondrial DAP3 engages IPS-1 spatially unclear"]},{"year":2010,"claim":"Identified DELE as a DAP3-binding sensitizer of death-receptor apoptosis, adding a partner that amplifies caspase activation.","evidence":"Yeast two-hybrid, Co-IP, overexpression/knockdown, caspase assays","pmids":["20563667"],"confidence":"Medium","gaps":["Mechanism of sensitization undefined","Single lab"]},{"year":2020,"claim":"Revealed an extra-mitochondrial RNA-regulatory function: DAP3 represses A-to-I editing by binding ADAR2 and displacing it from substrates, promoting tumorigenic unedited transcripts.","evidence":"Co-IP, domain mapping, RNA-IP, editome sequencing, PDZD7 recoding assays","pmids":["32596459"],"confidence":"Medium","gaps":["Subcellular site of DAP3-ADAR2 action not pinned","Relation to mitochondrial pool unclear"]},{"year":2022,"claim":"Showed DAP3 acts as a splicing regulatory RNA-binding protein, reshaping splicing both directly and via splicing factors, with WSB1 mis-splicing as a tumorigenic output.","evidence":"RNA-seq, RNA-IP, RNP Co-IP, TCGA analysis, WSB1 splicing validation","pmids":["35379802"],"confidence":"Medium","gaps":["RNP complex composition not fully defined","Direct vs. indirect splicing targets not separated"]},{"year":2023,"claim":"Linked DAP3 to the CHK1-dependent G2/M checkpoint in the radiation response, implicating it in cell-cycle control of cancer cells.","evidence":"siRNA, cell-cycle flow cytometry post-irradiation, phospho-CHK1/cdc2 westerns, CHK1 inhibitor epistasis","pmids":["37023702"],"confidence":"Medium","gaps":["Molecular mechanism connecting DAP3 to CHK1 unknown","Single lung adenocarcinoma context"]},{"year":2024,"claim":"Defined the mitochondrial molecular role: DAP3 promotes complex I via MT-ND5 translation, with AKT phosphorylation at Ser185 controlling its mitochondrial localization and function.","evidence":"Knockdown/overexpression, complex I assay, MT-ND5 western, Ser185 mutagenesis, fractionation, tumor models","pmids":["39080251"],"confidence":"Medium","gaps":["Whether DAP3 directly templates MT-ND5 translation not shown","Generality beyond HCC untested"]},{"year":2024,"claim":"Established DAP3 as a Mendelian mitochondrial disease gene, with loss-of-function variants impairing small-subunit assembly, OXPHOS, GTPase activity, and apoptotic sensitivity, rescuable by wild-type cDNA.","evidence":"Patient fibroblast proteomics, respiratory chain assays, lentiviral rescue, GTPase/thermal stability assays, structural modeling","pmids":["39701103"],"confidence":"High","gaps":["Genotype-phenotype correlations across patients limited","Structural basis of GTPase defect modeled but not solved"]},{"year":2024,"claim":"Showed DAP3 sustains m6A methylation by facilitating METTL3 binding and promoting MAT2A splicing/SAM production, tying its RNA functions to tumorigenesis.","evidence":"m6A-seq, RNA-IP, METTL3 RIP, MAT2A splicing/SAM assays, MAT2A rescue, tumor growth","pmids":["39316047"],"confidence":"Medium","gaps":["Whether m6A and mitochondrial functions are coupled unknown","Single lab"]},{"year":null,"claim":"How a single mitoribosomal GTPase coordinates its mitochondrial translation role with its nuclear/cytoplasmic RNA-regulatory and pro-apoptotic activities remains unresolved.","evidence":"No timeline study integrates the mitochondrial and extra-mitochondrial pools mechanistically","pmids":[],"confidence":"Low","gaps":["Pool partitioning between organelle and cytoplasm undefined","No structure of full-length human DAP3 in the mitoribosome reported","Causal link between translation function and RNA-editing/splicing roles unestablished"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[15]},{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[12,13,16]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[7,15]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,4]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[3,7,9,14]},{"term_id":"GO:0005840","term_label":"ribosome","supporting_discovery_ids":[8,15]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[4,12]}],"pathway":[{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[0,1,6,7,10]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[12,13,16]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7,14,15]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[15]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[17]}],"complexes":["mitochondrial small ribosomal subunit (mitoribosome)"],"partners":["FADD","CASP8","MAVS","DELE1","ADAR2","METTL3","NOA1","NR3C1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P51398","full_name":"Small ribosomal subunit protein mS29","aliases":["28S ribosomal protein S29, mitochondrial","MRP-S29","S29mt","Death-associated protein 3","DAP-3","Ionizing radiation resistance conferring protein"],"length_aa":398,"mass_kda":45.6,"function":"As a component of the mitochondrial small ribosomal subunit, it plays a role in the translation of mitochondrial mRNAs (PubMed:39701103). Involved in mediating interferon-gamma-induced cell death (PubMed:7499268). Displays GTPase activity in vitro (PubMed:39701103)","subcellular_location":"Mitochondrion","url":"https://www.uniprot.org/uniprotkb/P51398/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/DAP3","classification":"Common Essential","n_dependent_lines":948,"n_total_lines":1208,"dependency_fraction":0.7847682119205298},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CTCF","stoichiometry":0.2},{"gene":"HNRNPD","stoichiometry":0.2},{"gene":"HNRNPL","stoichiometry":0.2},{"gene":"HNRNPU","stoichiometry":0.2},{"gene":"IGF2BP1","stoichiometry":0.2},{"gene":"LSM14A","stoichiometry":0.2},{"gene":"PPM1G","stoichiometry":0.2},{"gene":"RBM39","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/DAP3","total_profiled":1310},"omim":[{"mim_id":"621101","title":"PERRAULT SYNDROME 7; PRLTS7","url":"https://www.omim.org/entry/621101"},{"mim_id":"615741","title":"DAP3-BINDING CELL DEATH ENHANCER 1; DELE1","url":"https://www.omim.org/entry/615741"},{"mim_id":"614919","title":"NITRIC OXIDE-ASSOCIATED PROTEIN 1; NOA1","url":"https://www.omim.org/entry/614919"},{"mim_id":"602074","title":"DEATH-ASSOCIATED PROTEIN 3; DAP3","url":"https://www.omim.org/entry/602074"},{"mim_id":"233400","title":"PERRAULT SYNDROME 1; PRLTS1","url":"https://www.omim.org/entry/233400"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Nucleoplasm","reliability":"Enhanced"},{"location":"Mitochondria","reliability":"Enhanced"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DAP3"},"hgnc":{"alias_symbol":["MRPS29","DAP-3","MRP-S29","bMRP-10","MGC126058","MGC126059","DKFZp686G12159","mS29"],"prev_symbol":[]},"alphafold":{"accession":"P51398","domains":[{"cath_id":"-","chopping":"62-345","consensus_level":"high","plddt":91.6785,"start":62,"end":345},{"cath_id":"-","chopping":"351-397","consensus_level":"medium","plddt":92.4298,"start":351,"end":397}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P51398","model_url":"https://alphafold.ebi.ac.uk/files/AF-P51398-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P51398-F1-predicted_aligned_error_v6.png","plddt_mean":85.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DAP3","jax_strain_url":"https://www.jax.org/strain/search?query=DAP3"},"sequence":{"accession":"P51398","fasta_url":"https://rest.uniprot.org/uniprotkb/P51398.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P51398/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P51398"}},"corpus_meta":[{"pmid":"7499268","id":"PMC_7499268","title":"Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7499268","citation_count":102,"is_preprint":false},{"pmid":"9889192","id":"PMC_9889192","title":"Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha- and Fas-induced cell death.","date":"1999","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9889192","citation_count":97,"is_preprint":false},{"pmid":"11489830","id":"PMC_11489830","title":"Death-associated protein 3 (Dap-3) is overexpressed in invasive glioblastoma cells in vivo and in glioma cell lines with induced motility phenotype in vitro.","date":"2001","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/11489830","citation_count":72,"is_preprint":false},{"pmid":"17135360","id":"PMC_17135360","title":"Mammalian dap3 is an essential gene required for mitochondrial homeostasis in vivo and contributing to the extrinsic pathway for apoptosis.","date":"2006","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/17135360","citation_count":49,"is_preprint":false},{"pmid":"15302871","id":"PMC_15302871","title":"Functional role of death-associated protein 3 (DAP3) in anoikis.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15302871","citation_count":47,"is_preprint":false},{"pmid":"19103604","id":"PMC_19103604","title":"hNOA1 interacts with complex I and DAP3 and regulates mitochondrial respiration and apoptosis.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19103604","citation_count":43,"is_preprint":false},{"pmid":"23735048","id":"PMC_23735048","title":"Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections.","date":"2013","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23735048","citation_count":42,"is_preprint":false},{"pmid":"32596459","id":"PMC_32596459","title":"Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression.","date":"2020","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/32596459","citation_count":38,"is_preprint":false},{"pmid":"18227431","id":"PMC_18227431","title":"Identification of phosphorylation sites in mammalian mitochondrial ribosomal protein DAP3.","date":"2008","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/18227431","citation_count":36,"is_preprint":false},{"pmid":"20563667","id":"PMC_20563667","title":"Identification of DELE, a novel DAP3-binding protein which is crucial for death receptor-mediated apoptosis induction.","date":"2010","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/20563667","citation_count":30,"is_preprint":false},{"pmid":"19644511","id":"PMC_19644511","title":"IPS-1 is crucial for DAP3-mediated anoikis induction by caspase-8 activation.","date":"2009","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/19644511","citation_count":29,"is_preprint":false},{"pmid":"22287761","id":"PMC_22287761","title":"The mRNA expression of DAP3 in human breast cancer: correlation with clinicopathological parameters.","date":"2012","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/22287761","citation_count":26,"is_preprint":false},{"pmid":"10903152","id":"PMC_10903152","title":"The pro-apoptotic protein death-associated protein 3 (DAP3) interacts with the glucocorticoid receptor and affects the receptor function.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10903152","citation_count":24,"is_preprint":false},{"pmid":"35379802","id":"PMC_35379802","title":"Multilayered control of splicing regulatory networks by DAP3 leads to widespread alternative splicing changes in cancer.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35379802","citation_count":21,"is_preprint":false},{"pmid":"15679048","id":"PMC_15679048","title":"Arg and DAP3 expression was correlated with human thymoma stage.","date":"2004","source":"Clinical & experimental metastasis","url":"https://pubmed.ncbi.nlm.nih.gov/15679048","citation_count":19,"is_preprint":false},{"pmid":"11162496","id":"PMC_11162496","title":"A conserved N-terminal sequence targets human DAP3 to mitochondria.","date":"2001","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/11162496","citation_count":15,"is_preprint":false},{"pmid":"12359235","id":"PMC_12359235","title":"TRAIL-induced apoptosis is independent of the mitochondrial apoptosis mediator DAP3.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12359235","citation_count":12,"is_preprint":false},{"pmid":"33401559","id":"PMC_33401559","title":"DAP3 Is Involved in Modulation of Cellular Radiation Response by RIG-I-Like Receptor Agonist in Human Lung Adenocarcinoma Cells.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33401559","citation_count":11,"is_preprint":false},{"pmid":"39080251","id":"PMC_39080251","title":"DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39080251","citation_count":10,"is_preprint":false},{"pmid":"12099703","id":"PMC_12099703","title":"Functional interaction between the pro-apoptotic DAP3 and the glucocorticoid receptor.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12099703","citation_count":10,"is_preprint":false},{"pmid":"20079882","id":"PMC_20079882","title":"Regulation of mitochondrial ribosomal protein S29 (MRPS29) expression by a 5'-upstream open reading frame.","date":"2010","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/20079882","citation_count":9,"is_preprint":false},{"pmid":"36382667","id":"PMC_36382667","title":"Death associated protein‑3 (DAP3) and DAP3 binding cell death enhancer‑1 (DELE1) in human colorectal cancer, and their impacts on clinical outcome and chemoresistance.","date":"2022","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/36382667","citation_count":9,"is_preprint":false},{"pmid":"38352299","id":"PMC_38352299","title":"Death-associated protein 3 in cancer-discrepant roles of DAP3 in tumours and molecular mechanisms.","date":"2024","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/38352299","citation_count":8,"is_preprint":false},{"pmid":"15179560","id":"PMC_15179560","title":"Association between genetic variation in the gene for death-associated protein-3 (DAP3) and adult asthma.","date":"2004","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15179560","citation_count":8,"is_preprint":false},{"pmid":"33952460","id":"PMC_33952460","title":"Expression of Death Associated Proteins DAP1 and DAP3 in Human Pancreatic Cancer.","date":"2021","source":"Anticancer research","url":"https://pubmed.ncbi.nlm.nih.gov/33952460","citation_count":7,"is_preprint":false},{"pmid":"1377490","id":"PMC_1377490","title":"Transfection of HLA-DR-expressing DAP.3 cells with a cDNA clone encoding the glycosyl phosphatidylinositol-linked form of lymphocyte function associated antigen-3: biochemical features and functional consequences.","date":"1992","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1377490","citation_count":7,"is_preprint":false},{"pmid":"38616861","id":"PMC_38616861","title":"DNA methylation of microRNA-365-1 induces apoptosis of hair follicle stem cells by targeting DAP3.","date":"2024","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/38616861","citation_count":6,"is_preprint":false},{"pmid":"14687027","id":"PMC_14687027","title":"Altered expression of Tfg and Dap3 in Ikaros-defective T-cell lymphomas induced by X-irradiation in B6C3F1 mice.","date":"2004","source":"British journal of haematology","url":"https://pubmed.ncbi.nlm.nih.gov/14687027","citation_count":6,"is_preprint":false},{"pmid":"39701103","id":"PMC_39701103","title":"Bi-allelic variants in DAP3 result in reduced assembly of the mitoribosomal small subunit with altered apoptosis and a Perrault-syndrome-spectrum phenotype.","date":"2024","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39701103","citation_count":6,"is_preprint":false},{"pmid":"37023702","id":"PMC_37023702","title":"DAP3-mediated cell cycle regulation and its association with radioresistance in human lung adenocarcinoma cell lines.","date":"2023","source":"Journal of radiation research","url":"https://pubmed.ncbi.nlm.nih.gov/37023702","citation_count":5,"is_preprint":false},{"pmid":"39316047","id":"PMC_39316047","title":"Modulation of m6A RNA modification by DAP3 in cancer cells.","date":"2024","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/39316047","citation_count":5,"is_preprint":false},{"pmid":"39371131","id":"PMC_39371131","title":"Biallelic variants in DAP3 result in reduced assembly of the mitoribosomal small subunit with altered intrinsic and extrinsic apoptosis and a Perrault syndrome-spectrum phenotype.","date":"2024","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39371131","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.08.19.24312079","title":"Biallelic variants in<i>DAP3</i>result in reduced assembly of the mitoribosomal small subunit with altered intrinsic and extrinsic apoptosis and a Perrault syndrome-spectrum phenotype","date":"2024-08-21","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.19.24312079","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":17310,"output_tokens":5337,"usd":0.065992,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13834,"output_tokens":5072,"usd":0.097985,"stage2_stop_reason":"end_turn"},"total_usd":0.163977,"stage1_batch_id":"msgbatch_01ACAxJQabDsht39JXeWG22d","stage2_batch_id":"msgbatch_01QEU22A9U5sbPTgsMzTmvSf","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"DAP3 was identified as a positive mediator of interferon-gamma-induced cell death in HeLa cells. Antisense RNA-mediated inactivation of DAP3 protected cells from IFN-γ-induced cell death, and ectopic overexpression was incompatible with cell growth. The protein carries a potential P-loop (nucleotide-binding) motif.\",\n      \"method\": \"Antisense cDNA library functional selection screen; antisense RNA knockdown; ectopic overexpression with colony-formation assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — functional genetic selection, antisense knockdown, and overexpression phenotype; foundational paper replicated by subsequent studies\",\n      \"pmids\": [\"7499268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Structure-function analysis showed that the intact full-length DAP3 protein is required for apoptosis induction when overexpressed, while the N-terminal 230 amino acids act in a dominant-negative fashion. Both activities depend on the integrity of the nucleotide-binding (P-loop) motif. Antisense DAP3 and the dominant-negative form protected cells from Fas- and TNF-α-induced apoptosis, placing DAP3 downstream of the receptor signaling complex; its death-promoting effect is caspase-dependent. A C. elegans ortholog induced cell death in mammalian cells upon overexpression.\",\n      \"method\": \"Antisense RNA knockdown; truncation/dominant-negative mutant overexpression; P-loop mutagenesis; caspase inhibitor epistasis; cross-species functional complementation\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (mutagenesis, dominant-negative, epistasis), replicated across stimuli and species\",\n      \"pmids\": [\"9889192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"DAP3 interacts with the glucocorticoid receptor (GR) ligand-binding domain in a ligand-dependent manner, identified by yeast two-hybrid and confirmed in vitro. The main interaction domain maps to the N-terminal region of DAP3. Co-transfection showed DAP3 stimulates ligand-induced GR transcriptional activation and increases steroid sensitivity. DAP3 also formed complexes with other nuclear receptors, bHLH/PAS proteins, and Hsp90.\",\n      \"method\": \"Yeast two-hybrid; in vitro binding assay; co-transfection transcriptional reporter assay; co-immunoprecipitation\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid plus in vitro interaction plus functional co-transfection assay, single lab\",\n      \"pmids\": [\"10903152\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"A conserved N-terminal sequence targets DAP3 to mitochondria. GFP fusion with the N-terminal region of human DAP3 localized exclusively to mitochondria in transfected human fibroblasts, confirmed by confocal microscopy. The mitochondrial targeting sequence is conserved in mouse, Drosophila, and C. elegans orthologs.\",\n      \"method\": \"N-terminal DAP3–EGFP fusion protein; confocal fluorescence microscopy in transfected human fibroblasts; in silico targeting prediction (MITOPROT, TargetP) with experimental validation\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct live-cell fluorescence localization with functional GFP fusion, single lab\",\n      \"pmids\": [\"11162496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Co-expression of DAP3 and GR results in increased cellular GR protein levels and partial translocation of DAP3 to the nucleus. The full-length DAP3 (not just the N-terminal domain) is required to efficiently increase GR levels and enhance GR transcriptional activity, indicating interplay between N- and C-termini for DAP3 cellular function.\",\n      \"method\": \"Co-transfection; western blot; subcellular fractionation/immunofluorescence for DAP3 localization; transcriptional reporter assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 / Moderate — functional co-expression data with domain dissection, single lab, two orthogonal readouts\",\n      \"pmids\": [\"12099703\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"DAP3 remains intra-mitochondrial during TRAIL-induced apoptosis and does not interact with FADD when subcellular compartments are intact. Interaction between DAP3 and FADD was only detectable in whole-cell lysate co-immunoprecipitation (i.e., an in vitro artifact after compartment disruption). TRAIL-induced, DR4-mediated apoptosis in Jurkat cells was found to be independent of DAP3.\",\n      \"method\": \"Cell fractionation; immunoprecipitation with intact vs. disrupted compartments; TRAIL-induced apoptosis in Jurkat cells with DAP3 analysis\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rigorous fractionation controls demonstrating compartment artifact, negative result well-supported; single lab\",\n      \"pmids\": [\"12359235\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"DAP3 is critical for anoikis induction. DAP3 knockdown (antisense oligonucleotides) inhibited anoikis, while overexpression augmented caspase activation upon cell detachment. Upon detachment, DAP3 associates with FADD and caspase-8 is activated. DAP3 is phosphorylated by Akt (PKB), and active Akt suppresses DAP3-induced apoptosis; mutation of the Akt phosphorylation consensus site in DAP3 renders it resistant to Akt suppression. Integrin ligation activates Akt, which phosphorylates DAP3 and suppresses anoikis.\",\n      \"method\": \"Antisense oligonucleotide knockdown; overexpression; co-immunoprecipitation (DAP3-FADD); caspase activation assay; Akt phosphorylation site mutagenesis; integrin ligation experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods including mutagenesis of phosphorylation site, Co-IP, functional rescue, and kinase assay in a single focused study\",\n      \"pmids\": [\"15302871\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"DAP3 is essential for embryonic viability in mice; dap3-/- embryos die at ~E9.5 with arrested development, shrunken mitochondria with swollen cristae (by TEM), and reduced cytochrome c oxidase-I (mitochondrial genome-encoded), consistent with a role in mitochondrial protein synthesis. siRNA knockdown reduced oxygen consumption in cultured cells. Cultured dap3-/- embryonic cells showed impaired apoptosis in response to extrinsic stimuli (TNFα, TRAIL, anti-Fas) but not intrinsic (mitochondrial) pathway stimuli.\",\n      \"method\": \"Knockout mouse generation; transmission electron microscopy; western blot for mtDNA-encoded protein (COX-I); siRNA knockdown + oxygen consumption measurement; cultured embryonic cell apoptosis assays with death receptor stimuli\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo KO phenotype combined with multiple orthogonal functional assays (TEM, respiration, apoptosis pathway specificity)\",\n      \"pmids\": [\"17135360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"DAP3 (mitochondrial ribosomal small subunit protein MRPS29) is phosphorylated in situ at Ser215 or Thr216, Ser220, Ser251 or Ser252, and Ser280, mapped by tandem mass spectrometry. Protein kinase A and Protein kinase Cδ can phosphorylate recombinant DAP3 at these same residues in vitro. Phosphorylation sites cluster around the conserved GTP-binding motifs. Site-directed mutagenesis of selected phosphorylation sites affected cell proliferation and PARP cleavage (caspase activation).\",\n      \"method\": \"Tandem mass spectrometry of immunopurified mitochondrial ribosomal DAP3; in vitro kinase assay with PKA and PKCδ; site-directed mutagenesis; PARP cleavage assay\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mass spectrometry phosphosite mapping + in vitro kinase validation + mutagenesis with functional readout, single lab\",\n      \"pmids\": [\"18227431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"hNOA1 (human homolog of AtNOA1, a large mitochondrial GTPase) physically interacts with DAP3 in mitochondria, identified by immunoprecipitation-mass spectrometry from enriched mitochondrial fractions. hNOA1 is peripherally associated with the inner mitochondrial membrane facing the matrix. Knockdown of hNOA1 renders cells more resistant to apoptotic stimuli (IFN-γ, staurosporine), consistent with a functional link through its DAP3 interaction.\",\n      \"method\": \"Immunoprecipitation-mass spectrometry from mitochondrial fractions; immunofluorescence; immunoelectron microscopy; mitochondrial subfractionation; siRNA knockdown + apoptosis assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — IP-MS interaction from native mitochondrial fractions plus functional knockdown phenotype, single lab\",\n      \"pmids\": [\"19103604\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"IPS-1 (interferon-beta promoter stimulator 1, also known as MAVS) binds DAP3 and is required for DAP3-mediated anoikis. Cell detachment induces IPS-1 expression, recruitment of caspase-8 to IPS-1, and caspase-8 activation. IPS-1 knockout mouse embryonic fibroblasts are resistant to anoikis. Knockdown of IPS-1 inhibits DAP3-mediated anoikis, placing IPS-1 downstream of or in concert with DAP3 in this pathway.\",\n      \"method\": \"Co-immunoprecipitation (IPS-1/DAP3 interaction); IPS-1 KO MEFs; siRNA knockdown of IPS-1; overexpression of IPS-1; caspase-3/-8/-9 activation assays; anoikis assay\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — Co-IP, genetic KO, siRNA knockdown, and overexpression with multiple caspase readouts in multiple orthogonal approaches\",\n      \"pmids\": [\"19644511\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Yeast two-hybrid screening identified DELE (death ligand signal enhancer) as a novel DAP3-binding protein. DELE interaction with DAP3 was confirmed in mammalian cells by co-immunoprecipitation. Stable DELE expression sensitized cells to TNF-α- and TRAIL-induced apoptosis; DELE knockdown rescued HeLa cells from apoptosis and significantly inhibited activation of caspase-3, -8, and -9 induced by TNF-α, anti-Fas, or TRAIL.\",\n      \"method\": \"Yeast two-hybrid screening; co-immunoprecipitation in mammalian cells; stable overexpression; siRNA knockdown; caspase activation assays\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — yeast two-hybrid confirmed by Co-IP with gain- and loss-of-function phenotyping, single lab\",\n      \"pmids\": [\"20563667\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DAP3 functions as a potent repressor of A-to-I RNA editing in cancer by directly interacting with the deaminase domain of ADAR2, disrupting ADAR2's association with its target transcripts. This suppression of editing leads to accumulation of unedited, more tumorigenic forms of target transcripts (e.g., PDZD7 without stop-codon recoding).\",\n      \"method\": \"Co-immunoprecipitation (DAP3-ADAR2 interaction); domain-mapping pulldown; RNA immunoprecipitation; editome sequencing; functional assays of PDZD7 recoding\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus RNA-IP plus functional RNA editing assays, single lab, multiple methods\",\n      \"pmids\": [\"32596459\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"DAP3 functions as a splicing regulatory RNA-binding protein in cancer. It coordinates splicing regulatory networks by mediating formation of ribonucleoprotein complexes to induce substrate-specific splicing changes, and also modulates splicing of splicing factors themselves, causing indirect widespread alternative splicing effects. Non-productive splicing of WSB1 was demonstrated as a causal DAP3-modulated mis-splicing event in tumorigenesis.\",\n      \"method\": \"RNA-seq splicing analysis; RNA immunoprecipitation; ribonucleoprotein complex co-immunoprecipitation; TCGA pan-cancer splicing analysis; functional WSB1 splicing validation\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-IP, RNP complex Co-IP, and functional validation of specific splicing target, single lab with pan-cancer computational validation\",\n      \"pmids\": [\"35379802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DAP3 promotes mitochondrial complex I activity in HCC cells by regulating translation and expression of the mitochondrial genome-encoded MT-ND5. AKT-mediated phosphorylation of DAP3 at Ser185 is the key event mediating its mitochondrial localization and function in HCC cells.\",\n      \"method\": \"siRNA knockdown; overexpression; mitochondrial complex I activity assay; western blot for MT-ND5; Ser185 phosphorylation site mutagenesis; subcellular fractionation; in vitro and in vivo tumor models\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional mutagenesis of phosphorylation site plus complex I activity assay plus localization, single lab, multiple methods\",\n      \"pmids\": [\"39080251\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Bi-allelic loss-of-function variants in DAP3 reduce MRPS29 (DAP3) protein levels, causing decreased assembly of the mitoribosomal small subunit and combined deficiency of oxidative phosphorylation complexes I and IV. Lentiviral rescue with wild-type DAP3 cDNA partially restored MRPS7, MRPS9, and complex I/IV subunit levels. In vitro assays showed DAP3 disease variants reduce GTPase activity, thermal stability, and both intrinsic and extrinsic apoptotic sensitivity. Protein modeling suggested variants impact ADP binding.\",\n      \"method\": \"Proteomic profiling of patient fibroblasts; respiratory chain activity measurement; lentiviral cDNA rescue; in vitro GTPase activity assay; thermal stability assay; apoptosis sensitivity assays; protein structural modeling\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multiple orthogonal methods (proteomics, enzymatic assay, genetic rescue, functional apoptosis assays) in a rigorous human genetics study\",\n      \"pmids\": [\"39701103\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DAP3 preserves m6A RNA methylation levels through two mechanisms: (1) it directly binds to m6A target regions on RNA, facilitating METTL3 binding to these sites; and (2) it promotes MAT2A last-intron splicing, increasing MAT2A protein, cellular SAM (methyl donor), and m6A levels. DAP3 silencing impairs tumorigenesis, which can be rescued by MAT2A overexpression.\",\n      \"method\": \"m6A sequencing; RNA immunoprecipitation; METTL3 ChIP/RIP; MAT2A splicing assay; SAM quantification; MAT2A overexpression rescue; tumor growth assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — RNA-IP plus m6A sequencing plus functional rescue, single lab, two orthogonal mechanistic pathways described\",\n      \"pmids\": [\"39316047\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"DAP3 knockdown attenuated radiation-induced G2/M cell cycle arrest in human lung adenocarcinoma cells and decreased expression of phosphorylated cdc2 (Tyr15) and phosphorylated CHK1 (Ser296). A CHK1 inhibitor phenocopied DAP3 loss in abrogating G2 arrest, placing DAP3 upstream of CHK1-mediated G2/M checkpoint regulation in the radiation response.\",\n      \"method\": \"siRNA knockdown of DAP3; flow cytometry cell cycle analysis after irradiation; western blot for phospho-cdc2, phospho-CHK1; CHK1 inhibitor epistasis; radiosensitivity assay\",\n      \"journal\": \"Journal of radiation research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — siRNA knockdown with pharmacological epistasis (CHK1 inhibitor), two orthogonal readouts, single lab\",\n      \"pmids\": [\"37023702\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DAP3 (MRPS29) is a GTP-binding protein of the mitoribosomal small subunit that is targeted to the mitochondrial matrix via a conserved N-terminal sequence, where it is required for mitoribosomal small subunit assembly and mitochondrial translation (especially of MT-ND5), supporting oxidative phosphorylation; it is regulated by phosphorylation at multiple sites (by PKA, PKCδ, and AKT at Ser185), with AKT-mediated phosphorylation also controlling its mitochondrial localization and apoptotic function; outside the mitoribosome, DAP3 acts as a positive mediator of extrinsic (Fas, TNF-α, TRAIL) apoptosis signaling downstream of death receptors in a caspase-dependent manner, interacting with partners including FADD (via IPS-1/MAVS scaffold), DELE1, and the glucocorticoid receptor; additionally, DAP3 functions in the nucleus/cytoplasm as an RNA-binding protein that suppresses A-to-I RNA editing by disrupting ADAR2–substrate interactions, regulates alternative splicing by forming ribonucleoprotein complexes and modulating splicing factor expression, and maintains m6A RNA methylation by facilitating METTL3 binding and promoting MAT2A splicing.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DAP3 (MRPS29) is a GTP-binding protein of the mitoribosomal small subunit that supports mitochondrial translation and a death-promoting signaling protein that mediates extrinsic apoptosis [#0, #7]. A conserved N-terminal sequence targets DAP3 to mitochondria, where it is required for synthesis of mitochondrial genome-encoded proteins and oxidative phosphorylation: dap3-null mouse embryos die at ~E9.5 with abnormal mitochondria and reduced COX-I, and DAP3 promotes complex I activity by controlling translation of MT-ND5 [#3, #7, #14]. Bi-allelic loss-of-function variants reduce DAP3 protein, impair small-subunit assembly, and cause combined OXPHOS complex I/IV deficiency, establishing DAP3 as a Mendelian mitochondrial disease gene [#15]. The death-promoting activity of DAP3 acts downstream of death receptors (Fas, TNF-\\u03b1) and during anoikis in a caspase-dependent manner, requiring an intact P-loop and full-length protein, and depends on partners including FADD, caspase-8, and the IPS-1/MAVS scaffold [#1, #6, #10]. DAP3 function is gated by phosphorylation: PKA and PKC\\u03b4 phosphorylate residues clustered around its GTP-binding motifs, and AKT phosphorylation at Ser185 controls both its mitochondrial localization and its suppression of apoptosis [#8, #6, #14]. Independently, DAP3 acts as an RNA-binding regulator in cancer, repressing A-to-I editing by disrupting ADAR2\\u2013substrate contacts, reshaping alternative splicing through ribonucleoprotein complexes, and sustaining m6A methylation by facilitating METTL3 binding and MAT2A splicing [#12, #13, #16].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established DAP3 as a required positive mediator of cytokine-induced cell death, defining its founding pro-apoptotic identity and flagging a nucleotide-binding motif as functionally central.\",\n      \"evidence\": \"Antisense functional selection screen and overexpression in HeLa cells\",\n      \"pmids\": [\"7499268\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of death promotion unresolved\", \"P-loop function not yet tested by mutagenesis\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Localized DAP3 action downstream of death receptors and showed its death activity is P-loop- and caspase-dependent, mapping where in the apoptotic cascade it operates.\",\n      \"evidence\": \"Dominant-negative/truncation and P-loop mutagenesis, caspase inhibitor epistasis, cross-species complementation\",\n      \"pmids\": [\"9889192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding partners in the receptor complex not identified\", \"Biochemical role of nucleotide binding unknown\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified DAP3 as a ligand-dependent glucocorticoid receptor coactivator, suggesting a nuclear-receptor regulatory role distinct from apoptosis.\",\n      \"evidence\": \"Yeast two-hybrid, in vitro binding, co-transfection reporter and Co-IP\",\n      \"pmids\": [\"10903152\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; physiological relevance unconfirmed\", \"Reconciliation with mitochondrial localization not addressed\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrated a conserved N-terminal mitochondrial targeting sequence, placing DAP3 in mitochondria and reframing its biology around organellar function.\",\n      \"evidence\": \"N-terminal DAP3-EGFP fusion and confocal microscopy in human fibroblasts\",\n      \"pmids\": [\"11162496\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Submitochondrial location not defined\", \"Function within mitochondria not yet shown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Clarified that the DAP3-FADD interaction reported in lysates is a compartment-disruption artifact and that TRAIL/DR4 apoptosis can proceed independently of DAP3, tempering the death-receptor model.\",\n      \"evidence\": \"Intact vs. disrupted compartment Co-IP and TRAIL apoptosis assays in Jurkat cells\",\n      \"pmids\": [\"12359235\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Context-dependence of DAP3-FADD interaction unresolved\", \"Single cell type tested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected DAP3 to anoikis and identified AKT phosphorylation as a switch suppressing its death function, linking integrin/survival signaling to DAP3 regulation.\",\n      \"evidence\": \"Antisense knockdown, overexpression, DAP3-FADD Co-IP, AKT site mutagenesis and integrin ligation\",\n      \"pmids\": [\"15302871\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Exact AKT site not yet mapped\", \"How phosphorylation alters DAP3 activity mechanistically unknown\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Proved DAP3 is essential for embryonic viability and mitochondrial protein synthesis/respiration, and that its requirement is specific to extrinsic apoptosis, unifying its mitochondrial and death roles in vivo.\",\n      \"evidence\": \"dap3 knockout mice, TEM, COX-I western, siRNA respiration assay, pathway-specific apoptosis assays\",\n      \"pmids\": [\"17135360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific mitoribosomal substrates not defined\", \"Molecular link between translation defect and apoptosis sensitivity unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapped DAP3 phosphosites clustering around its GTP-binding motifs and identified PKA/PKC\\u03b4 as kinases, showing phosphorylation tunes proliferation and caspase activation.\",\n      \"evidence\": \"Tandem MS phosphosite mapping, in vitro kinase assays, mutagenesis with PARP cleavage readout\",\n      \"pmids\": [\"18227431\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo stoichiometry and regulation of each site unknown\", \"Functional consequence per site not fully dissected\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Identified hNOA1 as a matrix-facing mitochondrial GTPase partner of DAP3 with a corresponding apoptosis phenotype, expanding the mitochondrial interactome.\",\n      \"evidence\": \"IP-MS from mitochondrial fractions, immuno-EM, subfractionation, siRNA apoptosis assay\",\n      \"pmids\": [\"19103604\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional consequence of the interaction for translation not shown\", \"Single lab\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Placed IPS-1/MAVS as a required partner in DAP3-mediated anoikis, providing a scaffold for caspase-8 recruitment during detachment.\",\n      \"evidence\": \"Co-IP, IPS-1 KO MEFs, siRNA/overexpression, caspase-3/8/9 assays, anoikis assay\",\n      \"pmids\": [\"19644511\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs. indirect DAP3-IPS-1 binding not resolved\", \"How mitochondrial DAP3 engages IPS-1 spatially unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified DELE as a DAP3-binding sensitizer of death-receptor apoptosis, adding a partner that amplifies caspase activation.\",\n      \"evidence\": \"Yeast two-hybrid, Co-IP, overexpression/knockdown, caspase assays\",\n      \"pmids\": [\"20563667\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of sensitization undefined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed an extra-mitochondrial RNA-regulatory function: DAP3 represses A-to-I editing by binding ADAR2 and displacing it from substrates, promoting tumorigenic unedited transcripts.\",\n      \"evidence\": \"Co-IP, domain mapping, RNA-IP, editome sequencing, PDZD7 recoding assays\",\n      \"pmids\": [\"32596459\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Subcellular site of DAP3-ADAR2 action not pinned\", \"Relation to mitochondrial pool unclear\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Showed DAP3 acts as a splicing regulatory RNA-binding protein, reshaping splicing both directly and via splicing factors, with WSB1 mis-splicing as a tumorigenic output.\",\n      \"evidence\": \"RNA-seq, RNA-IP, RNP Co-IP, TCGA analysis, WSB1 splicing validation\",\n      \"pmids\": [\"35379802\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"RNP complex composition not fully defined\", \"Direct vs. indirect splicing targets not separated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Linked DAP3 to the CHK1-dependent G2/M checkpoint in the radiation response, implicating it in cell-cycle control of cancer cells.\",\n      \"evidence\": \"siRNA, cell-cycle flow cytometry post-irradiation, phospho-CHK1/cdc2 westerns, CHK1 inhibitor epistasis\",\n      \"pmids\": [\"37023702\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism connecting DAP3 to CHK1 unknown\", \"Single lung adenocarcinoma context\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Defined the mitochondrial molecular role: DAP3 promotes complex I via MT-ND5 translation, with AKT phosphorylation at Ser185 controlling its mitochondrial localization and function.\",\n      \"evidence\": \"Knockdown/overexpression, complex I assay, MT-ND5 western, Ser185 mutagenesis, fractionation, tumor models\",\n      \"pmids\": [\"39080251\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether DAP3 directly templates MT-ND5 translation not shown\", \"Generality beyond HCC untested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established DAP3 as a Mendelian mitochondrial disease gene, with loss-of-function variants impairing small-subunit assembly, OXPHOS, GTPase activity, and apoptotic sensitivity, rescuable by wild-type cDNA.\",\n      \"evidence\": \"Patient fibroblast proteomics, respiratory chain assays, lentiviral rescue, GTPase/thermal stability assays, structural modeling\",\n      \"pmids\": [\"39701103\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype-phenotype correlations across patients limited\", \"Structural basis of GTPase defect modeled but not solved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showed DAP3 sustains m6A methylation by facilitating METTL3 binding and promoting MAT2A splicing/SAM production, tying its RNA functions to tumorigenesis.\",\n      \"evidence\": \"m6A-seq, RNA-IP, METTL3 RIP, MAT2A splicing/SAM assays, MAT2A rescue, tumor growth\",\n      \"pmids\": [\"39316047\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether m6A and mitochondrial functions are coupled unknown\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How a single mitoribosomal GTPase coordinates its mitochondrial translation role with its nuclear/cytoplasmic RNA-regulatory and pro-apoptotic activities remains unresolved.\",\n      \"evidence\": \"No timeline study integrates the mitochondrial and extra-mitochondrial pools mechanistically\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Pool partitioning between organelle and cytoplasm undefined\", \"No structure of full-length human DAP3 in the mitoribosome reported\", \"Causal link between translation function and RNA-editing/splicing roles unestablished\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [12, 13, 16]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [7, 15]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [3, 7, 9, 14]},\n      {\"term_id\": \"GO:0005840\", \"supporting_discovery_ids\": [8, 15]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [4, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [0, 1, 6, 7, 10]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [12, 13, 16]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7, 14, 15]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [15]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [17]}\n    ],\n    \"complexes\": [\"mitochondrial small ribosomal subunit (mitoribosome)\"],\n    \"partners\": [\"FADD\", \"CASP8\", \"MAVS\", \"DELE1\", \"ADAR2\", \"METTL3\", \"NOA1\", \"NR3C1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}